Why traditional Chinese medicine is difficult to develop overseas market

Recently, the UK drug and Health Administration (MHRA) officially announced that unregistered herbal products will be banned from sale as of April 30, 2014 In fact, no Chinese patent medicine has been successfully registered in China, which undoubtedly means that all the Chinese patent medicine stocks in the UK market will be removed According to reports and analysis, this move not only makes the local traditional Chinese medicine enterprises face the trend of bankruptcy, but also will cause the demonstration effect of EU countries As the birthplace of traditional Chinese medicine, China has always been difficult to make great achievements in the international market After the lament of a ban in the UK, we need to reflect on it What happened to the traditional Chinese medicine? Internationalization has been regarded as an important way for Chinese medicine industry to break through the difficulties, while the misreading of Chinese medicine in the international market has become a major obstacle to the development of Chinese medicine As early as a few months ago, the UK Drug Administration issued a warning on its official website to remind people to be cautious about buying traditional Chinese medicine products that have not been officially registered in the UK, and to guard against unsafe factors in pharmacology The ban is also mostly due to drug safety issues In fact, traditional Chinese medicine stresses "compatibility taboo, monarch, Minister and assistant envoy", that is to say, several drugs are coordinated with each other, which can enhance the curative effect and reduce the side effects Western medicine, however, is mostly a single drug preparation, and is used to studying the chemical components of Chinese herbal medicines, so it is usually unable to understand the "attack poison with poison" technique of traditional Chinese medicine However, the backwardness of the basic theoretical research of traditional Chinese medicine makes the Chinese industry unable to justify itself, and the lack of propaganda of traditional Chinese medicine culture makes it difficult to eliminate the misunderstanding and prejudice of traditional Chinese medicine in the West The era of "wine fragrance is not afraid of alley depth" has long gone If the Chinese pharmaceutical enterprises that are not internationally recognized remain self-confident, their development will inevitably be "blocked and long" In addition to the pharmacological differences between Chinese and Western medicine, the quality problems of Chinese medicine are also very serious In recent years, Chinese traditional medicine products have been seized frequently in many countries and regions due to heavy metals, pesticide residues and other toxins exceeding the standard, which has a great negative impact on the international reputation of Chinese traditional medicine industry The poor management and the lax quality control of our products are like digging our own grave, which makes the value of national treasures unable to be displayed China accounts for only 15% of the total trading volume of Chinese herbal medicines in the world, while Japan and South Korea, which have relatively weak resources, account for 20% each Distinct data is alarming us Only by strengthening the standardized management of traditional Chinese medicine, adapting to the international drug R & D and safety standard system, and promoting the modernization of traditional Chinese medicine, can traditional Chinese medicine enterprises truly go out of the country and bid farewell to the tragedy of "killing".